Publication | Closed Access

Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases

OncologyMedicinePathologyColorectal CancerAdvanced Solid TumoursPhase 1B/2Cancer TreatmentPharmacologyRadiation OncologyDose-expansion Phases